Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) — Cash Flow-to-Debt Ratio
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Cash Flow-to-Debt Ratio of 0.16x as of September 2025, meaning its operating cash flow of CN¥109.83 Million could theoretically repay 0% of its total liabilities (CN¥676.78 Million) in one year. See 600613 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A across 28 annual periods. For the full cash flow conversion analysis, see Shanghai Shenqi Pharmaceutical Investmen operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)
Year-by-year debt coverage analysis for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A. Check earnings quality score of Shanghai Shenqi Pharmaceutical Investmen to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥124.47 Million | CN¥747.59 Million | ▼ -44.8% |
| 2024 | 0.30x | CN¥207.79 Million | CN¥689.01 Million | ▲ +24.3% |
| 2023 | 0.24x | CN¥215.59 Million | CN¥888.77 Million | ▼ -23.4% |
| 2022 | 0.32x | CN¥319.23 Million | CN¥1.01 Billion | ▲ +30.0% |
| 2021 | 0.24x | CN¥184.26 Million | CN¥756.45 Million | ▲ +89.3% |
| 2020 | 0.13x | CN¥99.10 Million | CN¥770.28 Million | ▼ -10.3% |
| 2019 | 0.14x | CN¥128.28 Million | CN¥894.60 Million | ▼ -49.0% |
| 2018 | 0.28x | CN¥148.53 Million | CN¥527.74 Million | ▲ +137.5% |
| 2017 | 0.12x | CN¥66.99 Million | CN¥565.34 Million | ▲ +11689.9% |
| 2016 | 0.00x | CN¥570.41K | CN¥567.56 Million | ▼ -98.7% |
| 2015 | 0.08x | CN¥30.12 Million | CN¥384.98 Million | ▲ +332.0% |
| 2014 | -0.03x | CN¥-8.62 Million | CN¥255.60 Million | ▼ -108.3% |
| 2013 | 0.41x | CN¥74.75 Million | CN¥183.42 Million | ▲ +188.6% |
| 2012 | -0.46x | CN¥-11.18 Million | CN¥24.31 Million | ▼ -336.3% |
| 2011 | -0.11x | CN¥-3.33 Million | CN¥31.57 Million | ▼ -109.1% |
| 2010 | 1.16x | CN¥33.04 Million | CN¥28.48 Million | ▲ +814.1% |
| 2009 | 0.13x | CN¥7.69 Million | CN¥60.61 Million | ▼ -73.4% |
| 2008 | 0.48x | CN¥25.26 Million | CN¥53.04 Million | ▲ +168.5% |
| 2007 | 0.18x | CN¥16.01 Million | CN¥90.23 Million | ▲ +408.6% |
| 2006 | -0.06x | CN¥-6.05 Million | CN¥105.19 Million | ▼ -119.3% |
| 2005 | 0.30x | CN¥32.72 Million | CN¥109.67 Million | ▲ +1012.5% |
| 2004 | 0.03x | CN¥4.96 Million | CN¥184.98 Million | ▼ -16.9% |
| 2003 | 0.03x | CN¥4.52 Million | CN¥139.96 Million | ▼ -71.1% |
| 2002 | 0.11x | CN¥16.02 Million | CN¥143.38 Million | ▲ +185.6% |
| 2001 | -0.13x | CN¥-20.51 Million | CN¥157.14 Million | ▼ -182.1% |
| 2000 | 0.16x | CN¥26.85 Million | CN¥168.97 Million | ▲ +824.8% |
| 1999 | -0.02x | CN¥-3.28 Million | CN¥149.46 Million | ▼ -111.6% |
| 1998 | 0.19x | CN¥72.67 Million | CN¥384.28 Million | — |